Abstract
According to the World Health Organization (WHO) classification, tumors showing hematogenous spread in less than 2% of cases are categorized as “rarely metastasizing” and constitute a group of neoplasms of intermediate malignancy. Since its introduction in 2002, chondroblastoma has been considered one of the prototypic examples of this category of lesions. In the fifth and only recently published edition of the WHO classification of bone and soft tissue tumors, however, chondroblastoma was re-classified from rarely metastasizing to benign due to the rarity of cases with systemic spread. Here, we present a remarkable case of a 54-year-old male who presented with an expansile tumor in his left acromion that was diagnosed as chondroblastoma following biopsy. Three years later a local recurrence was noted during routine follow-up and a bone scan detected hypermetabolic lesions in a rib and the thoracic spine. Over time, he developed multifocal skeletal spread as well as soft tissue and pulmonary metastases, which histologically all revealed conventional chondroblastoma morphology and the highly specific H3-3B point mutation (p.Lys36Met). Thirteen years after initial diagnosis he is currently treated with experimental immunotherapy and shows stable but disseminated disease. Our case highlights that although metastasizing chondroblastoma is rare, potential systemic spread should be kept in mind in patients with chondroblastoma despite the new WHO classification.
Similar content being viewed by others
References
Pathology and genetics of tumours of soft tissue and bone. 3rd ed. Lyon, France: IARC Press, 2002.
Amary F, Cleven AHG, Konishi E. Chondroblastoma. World Health Organization classification of tumours. 5th ed. Lyon: IARC Press; 2020.
Kilpatrick SE, Parisien M, Bridge JA. Chondroblastoma. In: Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization classification of tumours. 3rd ed. Lyon: IARC Press; 2002.
Kilpatrick SE, Romeo S. Chondroblastoma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. World Health Organization classification of tumours. 4th ed. Lyon: IARC Press; 2013. p. 262–3.
Soft Tissue and Bone Tumours. 5th ed. Lyon: IARC Press, 2020.
Riddell RJ, Louis CJ, Bromberger NA. Pulmonary metastases from chondroblastoma of the tibia. Report of a case. J Bone Joint Surg Br. 1973;55(4):848–53.
Green P, Whittaker RP. Benign chondroblastoma. Case report with pulmonary metastasis. J Bone Joint Surg Am. 1975;57(3):418–20.
Wirman JA, Crissman JD, Aron BF. Metastatic chondroblastoma: report of an unusual case treated with radiotherapy. Cancer. 1979;44(1):87–93.
Ozkoc G, Gonlusen G, Ozalay M, Kayaselcuk F, Pourbagher A, Tandogan RN. Giant chondroblastoma of the scapula with pulmonary metastases. Skelet Radiol. 2006;35(1):42–8.
Tamura M, Oda M, Matsumoto I, Sawada-Kitamura S, Watanabe G. Chondroblastoma with pulmonary metastasis in a patient presenting with spontaneous bilateral pneumothorax: report of a case. Surg Today. 2011;41(10):1439–41.
Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013;45(12):1479–82.
Amary MF, Berisha F, Mozela R, Gibbons R, Guttridge A, O'Donnell P, et al. The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma. Histopathology. 2016;69(1):121–7.
Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469–74.
Luo J, Liu S, Leung S, Gru AA, Tao Y, Hoog J, et al. An mRNA gene expression-based signature to identify FGFR1-amplified estrogen receptor-positive breast tumors. J Mol Diagn. 2017;19(1):147–61.
John I, Inwards CY, Wenger DE, Williams DD, Fritchie KJ. Chondroblastomas presenting in adulthood: a study of 39 patients with emphasis on histological features and skeletal distribution. Histopathology. 2020;76(2):308–17.
Dhanda S, Menon S, Gulia A. Atypical giant chondroblastoma mimicking a chondrosarcoma. J Cancer Res Ther. 2015;11(3):660.
Gebert C, Hardes J, Streitburger A, Vieth V, Burger H, Winkelmann W, et al. Chondroblastoma of the acromion mimicking fibrous dysplasia. Acta Orthop Belg. 2004;70(6):616–8.
Funding
DB and BA were supported by the Swiss National Science Foundation, the Foundation of the Basel Bone Tumour Reference Centre, the Gertrude von Meissner Stiftung, and the Stiftung für krebskranke Kinder, Regio Basiliensis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Baumhoer, D., Harder, D., Ameline, B. et al. Metastasizing chondroblastoma: a rare bone tumor no longer supported by the WHO classification. Skeletal Radiol 50, 255–260 (2021). https://doi.org/10.1007/s00256-020-03525-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-020-03525-6